Loading...
Serum sickness with refractory nephrotic syndrome following treatment with rituximab
Rituximab (RTX) is effective for treating childhood refractory nephrotic syndrome (NS), such as steroid-dependent (SD), frequently relapsing (FR), and steroid-resistant (SR) NS. While RTX has been proven to be effective in treating SDNS, FRNS, and SRNS, it may cause serum sickness, a rare illness ch...
Na minha lista:
| Udgivet i: | CEN Case Rep |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Japan
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5886928/ https://ncbi.nlm.nih.gov/pubmed/29305810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-017-0297-7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|